Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment

Paul Harmatz1, Renee Shediac2

  • 1UCSF Benioff Children's Hospital Oakland, 747 52nd St., Oakland, CA 94609, United States of America, pharmatz@mail.cho.org.

Insights

Mucopolysaccharidosis VI (MPS VI) is a rare genetic disorder due to arylsulfatase B deficiency. New mass spectrometry methods show promise for diagnosing MPS VI, assessing its progression, and monitoring treatment effectiveness.

Area of Science:

  • Biochemistry
  • Genetics
  • Rare Diseases

Background:

  • Mucopolysaccharidosis VI (MPS VI), or Maroteaux-Lamy syndrome, is an autosomal recessive lysosomal storage disorder.
  • It results from deficient arylsulfatase B (ASB) activity, leading to progressive glycosaminoglycan (GAG) accumulation.
  • MPS VI exhibits significant genotypic and phenotypic diversity, impacting disease progression.

Purpose of the Study:

  • To highlight the diagnostic challenges and emerging methods for Mucopolysaccharidosis VI.
  • To discuss the current management strategies for MPS VI.
  • To emphasize the role of advanced analytical techniques in MPS VI care.

Main Methods:

  • Diagnosis relies on clinical evaluation, elevated urinary GAGs, low ASB activity in blood spots, and enzyme assays in leukocytes or fibroblasts.
  • Liquid chromatography/tandem mass spectrometry (LC-MS/MS) is utilized for analyzing GAG-derived disaccharides.
  • Assessment includes blood or urine sample analysis.

Main Results:

  • Traditional diagnostic methods include clinical signs, biochemical markers, and enzyme activity tests.
  • LC-MS/MS analysis of GAG-derived disaccharides in biological samples is emerging as a key technique.
  • This method offers potential for improved diagnosis, prognosis, and therapeutic monitoring in MPS VI.

Conclusions:

  • MPS VI diagnosis requires a combination of clinical and biochemical assessments.
  • Enzyme replacement therapy and symptomatic treatments are current management approaches.
  • Advanced mass spectrometry techniques are poised to enhance the clinical management of MPS VI.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.1K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
7.5K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
994
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
980
Biosynthesis of Polysaccharides01:26

Biosynthesis of Polysaccharides

Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
846